Natriuretic peptides in the diagnosis of heart disease - First amongst equals?

被引：12

作者：

Daly, C ^{[1
]}

Fox, K ^{[1
]}

Henein, M ^{[1
]}

机构：

[1] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, London SW3 6NP, England

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2002年 / 84卷 / 2-3期

关键词：

natriuretic peptides; heart failure; diagnostic markers;

D O I：

10.1016/S0167-5273(02)00143-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The natriuretic peptides and their role in neurohumoral regulation of the cardiovascular system have become the focus of considerable interest from the scientific and clinical community in recent years. BNP in particular has been shown to be an important diagnostic and prognostic marker of use in a wide range of applications. As measurement techniques develop and are refined, routine evaluation of serum levels of these markers is expected to become more widespread. We have reviewed the biochemistry of the natriuretic peptide family, their role in cardiovascular pathophysiology and the evidence supporting their use in the clinical setting. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.

引用

页码：107 / 113

页数：7

共 80 条

[1] Elevated plasma brain natriuretic peptide levels in chronic respiratory failure with cor pulmonale [J].

Bando, M ;

Ishii, Y ;

Sugiyama, Y ;

Kitamura, S .

RESPIRATORY MEDICINE, 1999, 93 (07) :507-514

[2]

Bevilacqua M, 1997, CLIN CHEM, V43, P2439

[3]

Brookes CIO, 1997, J HEART VALVE DIS, V6, P608

[4] PLASMA-CONCENTRATIONS AND COMPARISONS OF BRAIN NATRIURETIC PEPTIDE AND ATRIAL-NATRIURETIC-PEPTIDE IN NORMAL SUBJECTS, CARDIAC TRANSPLANT RECIPIENTS AND PATIENTS WITH DIALYSIS-INDEPENDENT OR DIALYSIS-DEPENDENT CHRONIC-RENAL-FAILURE [J].

BUCKLEY, MG ;

SETHI, D ;

MARKANDU, ND ;

SAGNELLA, GA ;

SINGER, DRJ ;

MACGREGOR, GA .

CLINICAL SCIENCE, 1992, 83 (04) :437-444

[5] Prolonged stability of brain natriuretic peptide: importance for non-invasive assessment of cardiac function in clinical practice [J].

Buckley, MG ;

Marcus, NJ ;

Yacoub, MH ;

Singer, DRJ .

CLINICAL SCIENCE, 1998, 95 (03) :235-239

[6] N-TERMINAL ATRIAL-NATRIURETIC-PEPTIDE AND ATRIAL-NATRIURETIC-PEPTIDE IN HUMAN PLASMA - INVESTIGATION OF PLASMA-LEVELS AND MOLECULAR CIRCULATING FORM(S) USING RADIOIMMUNOASSAYS FOR PROATRIAL NATRIURETIC PEPTIDE-(31-67), PROATRIAL NATRIURETIC PEPTIDE-(1-30) AND ATRIAL-NATRIURETIC-PEPTIDE-(99-126) [J].

BUCKLEY, MG ;

MARKANDU, ND ;

SAGNELLA, GA ;

MACGREGOR, GA .

CLINICAL SCIENCE, 1994, 87 (03) :311-317

[7] ATRIAL-NATRIURETIC-PEPTIDE ELEVATION IN CONGESTIVE-HEART-FAILURE IN THE HUMAN [J].

BURNETT, JC ;

KAO, PC ;

HU, DC ;

HESER, DW ;

HEUBLEIN, D ;

GRANGER, JP ;

OPGENORTH, TJ ;

REEDER, GS .

SCIENCE, 1986, 231 (4742) :1145-1147

[8] NATRIURETIC PEPTIDES INHIBIT DNA-SYNTHESIS IN CARDIAC FIBROBLASTS [J].

CAO, L ;

GARDNER, DG .

HYPERTENSION, 1995, 25 (02) :227-234

[9] Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure [J].

Clerico, A ;

Iervasi, G ;

Del Chicca, MG ;

Emdin, M ;

Maffei, S ;

Nannipieri, M ;

Sabatino, L ;

Forini, F ;

Manfredi, C ;

Donato, L .

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1998, 21 (03) :170-179

[10]

Clerico A, 2000, CLIN CHEM, V46, P1529

← 1 2 3 4 5 6 7 8 →